TRDANasdaq United States
Market cap
$267.495 M
$6.87 +0.00%
Close of 7 Aug 2026
Revenue
$25.4M
#2936 by revenue
Earnings
-$143.8M
Loss-making
Shares outstanding
38,936,669
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Entrada Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.